Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways.

Mol Cancer · 2022 · PMC9554963 · PMID 36221123

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

As a result, we observed highly significant antitumor activity and long-term survival of tumor-bearing mice [ 58 ].

also in 132,142 other papers

showed a trendno p-value reported

Combination therapies showed a trend toward an increased antiproliferative effect [ 140 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.